Asthmatic patients without currently treatment Asthma, ICS/LABA, Airway inflammation, FeNO
Conditions
Interventions
2 puffs twice daily of generic drug,2 puffs twice daily of original drug
Experimental Drug,Active Comparator Drug
Generic drug,Original drug
Sponsors
AeroCare And Inpac Pharma
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Patients with asthma who have not been treated with medicine, have stopped using medicine for more than 3 months, or have been diagnosed with a new asthma patient. (If there is no lung function test result may use clinical symptoms instead) 2. Do not smoke or have smoked for no more than 10-pack-years.
Exclusion criteria
Exclusion criteria: 1. Moderate to severe exacerbation within 1 month 2. History of respiratory tract infection within 1 month 3. Pregnancy 4. Using oral corticosteroid 5. Contraindication to be performed pulmonary function test
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Airway inflamation 4 weeks Exhale of nitric oxide (The change in number of level; ppb),Lung function 4 weeks Force expiratory volum in 1 second,Asthma control 4 weeks Asthma control test (Changing in ACT score or ACQ score),Anti-inflammatory response 4 weeks Absolute blood eosinophil count | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effect 4 weeks Self reported ( oral candidiasis, horseness, drug allerg, exacerbation of symptoms) | — |
Countries
Thailand
Contacts
Public ContactSiwadol Sunhapanit
Vajira hospital
Outcome results
None listed